![GregCasciaro GregCasciaro](https://www.cytokind.net/wp-content/uploads/2022/06/GregCasciaro-390x391.jpg)
Greg Casciaro – Chairman
Experienced Chief Executive Officer with a demonstrated history of working in the medical device industry. Former President & CEO of Cardiac Dimensions Inc., Access Closure Inc., Orquest, Inc., and General Surgical Innovations.
![John MacMahon John MacMohn](https://www.cytokind.net/wp-content/uploads/2020/05/John-MacMahon-390x391.jpg)
John MacMahon – CTO, co-founder
Expert in early-stage medical device and first-in-man clinical trials. Former founder and CEO of Kerberos Proximal Solutions (sold to FHT), COO for Maya Medical (sold to COV) and General Manager for Claret (sold to BSX).
![Untitled-design-1 Untitled-design-1](https://www.cytokind.net/wp-content/uploads/2021/05/Untitled-design-1-390x391.jpg)
Iva Kaufman – Advocacy & Outreach
Iva Kaufman applies an interdisciplinary approach to business and philanthropy, social finance, funding, in both commercial and not-for-profit management.
![](https://www.cytokind.net/wp-content/uploads/2021/05/craig-ullman-3.jpeg)
Craig Ullman – General Manager
Senior operations executive focusing on technology startups with successful exits. He is also a named inventor on numerous foundational patents, including 2 of the first fifty on the Word Wide Web, and winner of Digital Luminary Award
![](https://www.cytokind.net/wp-content/uploads/2020/05/Carmen-Castilla-1.jpg)
Carmen Castilla – Director of Clinical Phototherapy
MD Medical Dermatologist at New York Dermatology Group. Dr. Castilla sees the skin’s critical interplay with the systemic immune system as an important and non-invasive pathway to systemic immunomodulation.
![](https://www.cytokind.net/wp-content/uploads/2020/05/Ben-Wang.png)
Ben Wang – Chief Science Officer
PhD CEO of Chimera Bioengineering and co-founder of Cytokind, specializing in intersectional scientific and engineering in immunology. At Chimera, Ben is focused on controlling immune toxicity and cytokine release syndromes endemic in CAR-T therapy.